Copyright Reports & Markets. All rights reserved.

Global Point of Care Diagnostics (POCD) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Blood Glucose Testing
    • 1.3.3 Infectious Diseases Testing
    • 1.3.4 Cardiac Markers Testing
    • 1.3.5 Coagulation Testing
    • 1.3.6 Pregnancy and Fertility Testing
    • 1.3.7 Blood Gas/Electrolytes Testing
    • 1.3.8 Tumor Markers Testing
    • 1.3.9 Urinalysis Testing
    • 1.3.10 Cholesterol Testing
    • 1.3.11 Others
  • 1.4 Market by Application
    • 1.4.1 Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2026
    • 1.4.2 Clinics
    • 1.4.3 Hospitals
    • 1.4.4 Assisted Living Healthcare Facilities
    • 1.4.5 Laboratory
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2015-2026)
  • 2.2 Point of Care Diagnostics (POCD) Growth Trends by Regions
    • 2.2.1 Point of Care Diagnostics (POCD) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Point of Care Diagnostics (POCD) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Point of Care Diagnostics (POCD) Industry Dynamic
    • 2.3.1 Point of Care Diagnostics (POCD) Market Trends
    • 2.3.2 Point of Care Diagnostics (POCD) Market Drivers
    • 2.3.3 Point of Care Diagnostics (POCD) Market Challenges
    • 2.3.4 Point of Care Diagnostics (POCD) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Point of Care Diagnostics (POCD) Players by Market Size
    • 3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2015-2020)
    • 3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
  • 3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
    • 3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2019
  • 3.5 Key Players Point of Care Diagnostics (POCD) Area Served
  • 3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
  • 3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care Diagnostics (POCD) Breakdown Data by Type

  • 4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2015-2020)
  • 4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2021-2026)

5 Point of Care Diagnostics (POCD) Breakdown Data by Application

  • 5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2015-2020)
  • 5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Point of Care Diagnostics (POCD) Market Size (2015-2026)
  • 6.2 North America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
  • 6.3 North America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
  • 6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Point of Care Diagnostics (POCD) Market Size (2015-2026)
  • 7.2 Europe Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
  • 7.3 Europe Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
  • 7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2015-2026)
  • 8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2015-2026)
  • 9.2 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
  • 9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
  • 9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2015-2026)
  • 10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Alere
    • 11.1.1 Alere Company Details
    • 11.1.2 Alere Business Overview
    • 11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
    • 11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2015-2020))
    • 11.1.5 Alere Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
    • 11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.2.5 Roche Recent Development
  • 11.3 Abbott Laboratories
    • 11.3.1 Abbott Laboratories Company Details
    • 11.3.2 Abbott Laboratories Business Overview
    • 11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
    • 11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.3.5 Abbott Laboratories Recent Development
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Company Details
    • 11.4.2 Johnson & Johnson Business Overview
    • 11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
    • 11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.4.5 Johnson & Johnson Recent Development
  • 11.5 Siemens Healthcare
    • 11.5.1 Siemens Healthcare Company Details
    • 11.5.2 Siemens Healthcare Business Overview
    • 11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
    • 11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.5.5 Siemens Healthcare Recent Development
  • 11.6 Danaher
    • 11.6.1 Danaher Company Details
    • 11.6.2 Danaher Business Overview
    • 11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
    • 11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.6.5 Danaher Recent Development
  • 11.7 QIAGEN
    • 11.7.1 QIAGEN Company Details
    • 11.7.2 QIAGEN Business Overview
    • 11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
    • 11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.7.5 QIAGEN Recent Development
  • 11.8 Bayer Healthcare
    • 11.8.1 Bayer Healthcare Company Details
    • 11.8.2 Bayer Healthcare Business Overview
    • 11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
    • 11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.8.5 Bayer Healthcare Recent Development
  • 11.9 Beckman Coulter
    • 11.9.1 Beckman Coulter Company Details
    • 11.9.2 Beckman Coulter Business Overview
    • 11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
    • 11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.9.5 Beckman Coulter Recent Development
  • 11.10 Nipro Diagnostics
    • 11.10.1 Nipro Diagnostics Company Details
    • 11.10.2 Nipro Diagnostics Business Overview
    • 11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
    • 11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 11.10.5 Nipro Diagnostics Recent Development
  • 11.11 Bio-Rad Laboratories
    • 10.11.1 Bio-Rad Laboratories Company Details
    • 10.11.2 Bio-Rad Laboratories Business Overview
    • 10.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
    • 10.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.11.5 Bio-Rad Laboratories Recent Development
  • 11.12 Nova Biomedical
    • 10.12.1 Nova Biomedical Company Details
    • 10.12.2 Nova Biomedical Business Overview
    • 10.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
    • 10.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.12.5 Nova Biomedical Recent Development
  • 11.13 BioMerieux
    • 10.13.1 BioMerieux Company Details
    • 10.13.2 BioMerieux Business Overview
    • 10.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
    • 10.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.13.5 BioMerieux Recent Development
  • 11.14 Quidel
    • 10.14.1 Quidel Company Details
    • 10.14.2 Quidel Business Overview
    • 10.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
    • 10.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.14.5 Quidel Recent Development
  • 11.15 Helena Laboratories
    • 10.15.1 Helena Laboratories Company Details
    • 10.15.2 Helena Laboratories Business Overview
    • 10.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
    • 10.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.15.5 Helena Laboratories Recent Development
  • 11.16 OraSure Technologies
    • 10.16.1 OraSure Technologies Company Details
    • 10.16.2 OraSure Technologies Business Overview
    • 10.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
    • 10.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.16.5 OraSure Technologies Recent Development
  • 11.17 Accriva
    • 10.17.1 Accriva Company Details
    • 10.17.2 Accriva Business Overview
    • 10.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
    • 10.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.17.5 Accriva Recent Development
  • 11.18 Abaxis
    • 10.18.1 Abaxis Company Details
    • 10.18.2 Abaxis Business Overview
    • 10.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
    • 10.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.18.5 Abaxis Recent Development
  • 11.19 Chembio Diagnostics
    • 10.19.1 Chembio Diagnostics Company Details
    • 10.19.2 Chembio Diagnostics Business Overview
    • 10.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
    • 10.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.19.5 Chembio Diagnostics Recent Development
  • 11.20 Trinity Biotech
    • 10.20.1 Trinity Biotech Company Details
    • 10.20.2 Trinity Biotech Business Overview
    • 10.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
    • 10.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.20.5 Trinity Biotech Recent Development
  • 11.21 Instrumentation Laboratory
    • 10.21.1 Instrumentation Laboratory Company Details
    • 10.21.2 Instrumentation Laboratory Business Overview
    • 10.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
    • 10.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.21.5 Instrumentation Laboratory Recent Development
  • 11.22 Sekisui Diagnostics
    • 10.22.1 Sekisui Diagnostics Company Details
    • 10.22.2 Sekisui Diagnostics Business Overview
    • 10.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
    • 10.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
    • 10.22.5 Sekisui Diagnostics Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Point of Care Diagnostics (POCD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostics (POCD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Blood Glucose Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Pregnancy and Fertility Testing
    Blood Gas/Electrolytes Testing
    Tumor Markers Testing
    Urinalysis Testing
    Cholesterol Testing
    Others

    Market segment by Application, split into
    Clinics
    Hospitals
    Assisted Living Healthcare Facilities
    Laboratory

    Based on regional and country-level analysis, the Point of Care Diagnostics (POCD) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Point of Care Diagnostics (POCD) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Alere
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Siemens Healthcare
    Danaher
    QIAGEN
    Bayer Healthcare
    Beckman Coulter
    Nipro Diagnostics
    Bio-Rad Laboratories
    Nova Biomedical
    BioMerieux
    Quidel
    Helena Laboratories
    OraSure Technologies
    Accriva
    Abaxis
    Chembio Diagnostics
    Trinity Biotech
    Instrumentation Laboratory

    Buy now